2006-5-1
‰»Šw‰οŽΠ‚ΜŠCŠOioˆκ—— ƒ^ƒJƒ‰ƒoƒCƒI ’†‘

2002/4 •σŽπ‘’‚ΜƒoƒCƒIŽ–‹Ζ‚π•ͺŠ„‚΅‚ĐVέ


ˆβ“`ŽqŽ‘—Γ‚βˆβ“`ŽqHŠw‚ΜŒ€‹†ŠJ”­‚Ɛ»•i‚Μ”Μ”„

ŽΠ–Ό •σ“ϊˆγΆ•¨‹Zpi–k‹žj—LŒΐŒφŽi
@@Takara Biomedical TechnologyiBeijing) Co., Ltd.
κŠ –k‹žŽsΉ•½‹ζ‰ρ—΄ŠΟ’†ŠΦ‘ΊΆ–½‰ΘŠw‰€
Š”Žε ƒ^ƒJƒ‰ƒoƒCƒI 100%
έ—§ 2004/1
@@http://www.takara-bio.co.jp/news/2004/02/03.htm@
”\—Ν @
”υl @

@

ˆβ“`ŽqHŠwŒ€‹†—pŽŽ–ς‚̐ΆŽY

ŽΠ–Ό •σΆ•¨H’φi‘ε˜Aj—LŒΐŒφŽi
κŠ —Ι”JΘ‘ε˜AŽs
Š”Žε ƒ^ƒJƒ‰ƒoƒCƒI 100%@i2006/2j
@@“–‰‚́@ƒ^ƒJƒ‰ƒoƒCƒI 97.5%
@@@@@@@ŠΫg@@2.5%
έ—§ 1993
”\—Ν @
”υl 100%Žq‰οŽΠ‰»@http://www.takara-bio.co.jp/news/2006/02/23.htm

@

@